# CNS Pharmaceuticals, Inc.: Form 8-K, filed Feb 17, 2026

- Company: [CNS Pharmaceuticals, Inc.](/companies/cnsp.md) (CIK 1729427)
- Form: 8-K
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 13:35 ET
- Period: 2026-02-10
- Accession: 0001683168-26-001066
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729427/000168316826001066/cns_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729427/000168316826001066/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729427/000168316826001066/cns_8k.htm

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001683168-26-001066. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.